Testosterone therapy does not appear to worsen outcomes in men with COVID-19

Data showed that 87.8% of treated patients and 96.1% of patients who completed the study achieved normal 24-hour mean plasma testosterone values (222 to 800 ng/dL) at 90-day follow-up.

“I think it's really important to understand the role of prevention and early detection,” says Michael Lutz, MD.

The study is set to begin in January 2024.

“I think that the audience should know that there is a movement going on,” says Geo Espinosa, ND.

If replicated with further study, the finding potentially expands noninvasive fertility treatment options and may minimize the need for expensive reproductive technology, according to lead author Scott D. Lundy, MD, PhD, of Cleveland Clinic’s Department of Urology.

The inclusion of PAE in the American Urological Association BPH Guidelines offers a non-surgical alternative that can provide long-term relief with minimal downtime and fewer complications, according to the United Urology Group.